{{Rsnum
|rsid=10054504
|Gene=PDZD2
|Chromosome=5
|position=32000377
|Orientation=plus
|GMAF=0.4155
|Gene_s=PDZD2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 78.8 | 21.2 | 0.0
| HCB | 8.1 | 41.2 | 50.7
| JPT | 9.7 | 52.2 | 38.1
| YRI | 6.8 | 44.9 | 48.3
| ASW | 17.5 | 52.6 | 29.8
| CHB | 8.1 | 41.2 | 50.7
| CHD | 15.6 | 44.0 | 40.4
| GIH | 65.3 | 30.7 | 4.0
| LWK | 8.2 | 50.0 | 41.8
| MEX | 55.2 | 39.7 | 5.2
| MKK | 20.0 | 48.4 | 31.6
| TSI | 72.5 | 25.5 | 2.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23184150
  |Trait=Renal cell carcinoma
  |Title=Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer.
  |RiskAllele=
  |Pval=8E-7
  |OR=1.37
  |ORtxt=[1.19-1.58]
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}